pCODRExpertReviewCommittee(pERC)
RequiresTwoPatientMembers
ThepCODRExpertReviewCommittee(pERC)islookingfortwoPatientMemberswhohaveeitherfirst‐
handexperiencewiththetreatmentandcareofcancerorafamilymemberofacancerpatientwhohas
developed,first‐hand,anunderstandingofthetreatmentandcareofcancer.Composedofupto16
members,thepERCwillmakerecommendationsandprovideadvicetotheMinistriesofHealthand
canceragencies.
Background:Thenewlyestablishedpan‐CanadianOncologyDrugReview(pCODR)willassessthe
clinicalevidenceandcosteffectivenessofnewcancerdrugs,andtousethisinformationtomake
recommendationstotheprovincesandterritoriesinguidingtheirdrugfundingdecisions.
DesiredQualifications:Thesuccessfulcandidateswillhavepersonalknowledgeof,experiencewith,
andunderstandingofissuesrelatedtocanceranditsmanagement(diagnosis,treatment,andcare).
Theywillalsohaveademonstratedunderstandingandappreciationofpatientneedsandprioritiesand
anoverallunderstandingofotherpatientissuesandhealthcareconcernsthatmayimpactcancer
patientcommunities.
Successfulcandidatesshouldalsopossessthefollowing:
• Strongcommunicationandinterpersonalskillstobeabletoworkconstructivelyasamemberof
ateam
• Abilitytoactwithintegrityandindependenceofspecificinterestsandgainrespectand
credibilitywithinadiverserangeofstakeholders
• Open‐mindedanddiplomaticandabletorelatetoandrespectadiverserangeofvaluesan
beliefs
MembersofthepERCareexpectedtoprepareforandattendupto12meetingsperyear;ableto
complywiththepCODR’sConflictofInterestandConfidentialityrequirements.Nopersoncurrently
employedbyanypharmaceuticalorrelatedcompanywillbeconsidered.MembersofthepERCwill
receiveamodestremuneration.
Allapplicantswillreceiveconfirmationofreceiptoftheirapplication.Whilewethankallapplicantsfor
theirsubmission,onlythoseunderfurtherconsiderationwillbecontactedpersonally.
AllapplicationsmustbereceivedbyJanuary21,2011.
Formoreinformationandhowtoapply,pleasevisitwww.hrassociates.ca/pcodr